S
Stephanie Kemp
Researcher at Stanford University
Publications - 88
Citations - 8526
Stephanie Kemp is an academic researcher from Stanford University. The author has contributed to research in topics: Stroke & Perfusion scanning. The author has an hindex of 34, co-authored 83 publications receiving 7268 citations. Previous affiliations of Stephanie Kemp include University of California, Los Angeles & University of Southern California.
Papers
More filters
Journal ArticleDOI
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers,Michael P. Marks,Stephanie Kemp,Soren Christensen,Jenny P Tsai,Santiago Ortega-Gutierrez,Ryan A McTaggart,Michel T. Torbey,May Kim-Tenser,Thabele M Leslie-Mazwi,Amrou Sarraj,Scott E. Kasner,Sameer A. Ansari,Sharon D. Yeatts,Scott Hamilton,Michael Mlynash,Jeremy J Heit,Greg Zaharchuk,Sun Kim,Janice Carrozzella,Yuko Y. Palesch,Andrew M. Demchuk,Roland Bammer,Philip W. Lavori,Joseph P. Broderick,Maarten G Lansberg +25 more
TL;DR: Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical Therapy alone among patients with proximal middle‐cerebral‐artery or internal‐carotid‐arterY occlusion and a region of tissue that was ischeMIC but not yet infarcted.
Journal ArticleDOI
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.
Gregory W. Albers,Vincent Thijs,Lawrence R. Wechsler,Stephanie Kemp,Gottfried Schlaug,Elaine Skalabrin,Roland Bammer,Wataru Kakuda,Maarten G Lansberg,Ashfaq Shuaib,William Coplin,Scott Hamilton,Michael E. Moseley,Michael P. Marks +13 more
TL;DR: For stroke patients treated 3 to 6 hours after onset, baseline MRI findings can identify subgroups that are likely to benefit from reperfusion therapies and can potentially identify sub groups that are unlikely to benefit or may be harmed.
Journal ArticleDOI
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
Maarten G Lansberg,Matus Straka,Stephanie Kemp,Michael Mlynash,Lawrence R. Wechsler,Tudor G Jovin,Michael J Wilder,Helmi L. Lutsep,Todd Czartoski,Richard A. Bernstein,Cherylee W.J. Chang,Steven Warach,Franz Fazekas,Manabu Inoue,Aaryani Tipirneni,Scott Hamilton,Greg Zaharchuk,Michael P. Marks,Roland Bammer,Gregory W. Albers +19 more
TL;DR: Target mismatch patients who had early reperfusion after endovascular stroke treatment had more favourable clinical outcomes and a randomised controlled trial of endov vascular treatment for patients with the target mismatch profile is warranted.
Journal ArticleDOI
Optimal Tmax threshold for predicting penumbral tissue in acute stroke.
Jean-Marc Olivot,Michael Mlynash,Vincent Thijs,Stephanie Kemp,Maarten G Lansberg,Lawrence R. Wechsler,Roland Bammer,Michael P. Marks,Gregory W. Albers +8 more
TL;DR: Defining PWI lesions based on a stricter Tmax threshold than the standard >2 seconds delay appears to provide more a reliable estimate of the volume of the ischemic penumbra in stroke patients imaged between 3 and 6 hours after symptom onset.
Journal ArticleDOI
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).
Gregory W. Albers,Maarten G Lansberg,Stephanie Kemp,Jenny P Tsai,Phil Lavori,Soren Christensen,Michael Mlynash,Sun Kim,Scott Hamilton,Sharon D. Yeatts,Yuko Y. Palesch,Roland Bammer,Joseph P. Broderick,Michael P. Marks +13 more
TL;DR: Among patients with large vessel anterior circulation occlusion who have a favorable imaging profile on computed tomography perfusion or magnetic resonance imaging, endovascular therapy with a Food and Drug Administration 510 K-cleared mechanical thrombectomy device reduces the degree of disability three months post stroke.